The American Urological Association Symptom Index for Benign Prostatic Hyperplasia

A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of urology Vol. 197; no. 2; pp. S189 - S197
Main Authors Barry, Michael J, Fowler, Floyd J, O'leary, Michael P, Bruskewitz, Reginald C, Holtgrewe, H. Logan, Mebust, Winston K, Cockett, Abraham T.K
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2017
Subjects
Adult
Aged
Aged, 80 and over
Case-Control Studies
Humans
Interdisciplinary Communication
Male
Middle Aged
prostatic diseases
Prostatic Hyperplasia - diagnosis
Prostatic Hyperplasia - physiopathology
prostatic hypertrophy
Quality of Life
Reproducibility of Results
ROC Curve
Severity of Illness Index
Societies, Medical
statistics
United States
Urination - physiology
Urodynamics - physiology
Urology
Young Adult
United States
prostatic hypertrophy
prostatic diseases
statistics
Online AccessGet full text

Cover

More Information
Summary:A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach's α = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects' global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p <0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0022-5347
1527-3792
1527-3792
DOI:10.1016/j.juro.2016.10.071